
Katg Therapeutics Private Limited
About Katg Therapeutics Private Limited
Data last updated:
Katg Therapeutics Private Limited was a private limited company based in Secunderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 September 1996.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1996PTC025232. Its GSTIN is 36AADCK5353L1Z9 (Telangana).
The company had an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It was led by directors Sudhakar Reddy Kondamareddychinna and Kondamareddy Sarada.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at 8 – 289 Goutam Nagar Ferozguda, Secunderabad, Telangana, India – 500011.
As per the financials filed for FY 2017, the company reported a revenue of ₹27.3 Lakh. For the same year it recorded a net profit of ₹84,031 (net margin 3.1%) and EBITDA of ₹5.66 Lakh (EBITDA margin 20.8%).
As per MCA filings, the company had satisfied charges of ₹1 Cr on record.
Company details
CIN history
Katg Therapeutics has one previous CIN (Corporate Identification Number): U24230AP1996PTC025232. The current CIN is U24230TG1996PTC025232, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1996PTC025232 | Current |
| U24230AP1996PTC025232 | Previous |
Contact details
Katg Therapeutics Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address8 – 289 Goutam Nagar Ferozguda, Secunderabad, Telangana, India – 500011
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Katg Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Katg Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Katg Therapeutics Private Limited
FY 2022 filings availableKatg Therapeutics Private Limited reported revenue of ₹27.3 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹27.3 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹5.66 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹84,031 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 20.8% | ||
| Net Profit Margin | 3.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Katg Therapeutics Private Limited, buy the company report.
Board of directors of Katg Therapeutics Private Limited
Katg Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhakar Reddy Kondamareddychinna | Director | 17 Sep 1996 | 30 Years 1 Months | As last reported |
| Kondamareddy Sarada | Director | 27 Mar 2002 | 24 Years 7 Months | As last reported |
Auditor
Katg Therapeutics Private Limited is audited by H SATYANARAYANA REDDY & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H SATYANARAYANA REDDY & CO | FY 2017 | 005644S |
Shareholding
The shareholding of Katg Therapeutics Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Katg Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Aug 2006 | 10015697 | Bank of Baroda | ₹1 Cr | Satisfied |
To see the full charge records of Katg Therapeutics Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Katg Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Katg Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Katg Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCK5353L1Z9 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Katg Therapeutics Private Limited, buy the company report.
Recent activity
Katg Therapeutics Private Limited has 4 board changes on record since 1996: 2 appointments and 2 cessations. The latest: Ravi Kiran Kondamareddy ceased to be Director on 10 Sep 2018.
Frequently asked questions
Katg Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Katg Therapeutics was a private limited company based in Secunderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 17 September 1996 and is registered under CIN U24230TG1996PTC025232. The company has been struck off by the Registrar of Companies and is no longer operational.
Katg Therapeutics had 2 directors:
- Sudhakar Reddy Kondamareddychinna - Director
- Kondamareddy Sarada - Director
The CIN (Corporate Identification Number) of Katg Therapeutics is U24230TG1996PTC025232. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Katg Therapeutics is at 8 – 289 Goutam Nagar Ferozguda, Secunderabad, Telangana, India – 500011.
Katg Therapeutics was incorporated on 17 September 1996. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Katg Therapeutics on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Katg Therapeutics is 36AADCK5353L1Z9, registered in Telangana.
Katg Therapeutics operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Ravi Kiran Kondamareddy ceased to be Director on 10 Sep 2018. Sudhakar Andalamala ceased to be Director on 10 Jul 2015. Kondamareddy Sarada was appointed as Director on 27 Mar 2002. Katg Therapeutics has 4 board changes on record in total.

